Catumaxomab

A trifunctional bispecific monoclonal antibody with potential antineoplastic activity. Catumaxomab has two antigen-recognition sites: one for human CD3, a T cell surface antigen; and one for human epithelial cell adhesion molecule (EpCAM), a cell surface antigen expressed by a variety of epithelial tumor cells. In addition, the modified Fc portion of this antibody binds Fc receptors on antigen presenting cells (APCs) such as macrophages and dendritic cells (DCs). Catumaxomab brings T cells, EpCAM-expressing epithelial tumor cells and APCs together into tricellular complexes, which may result in a potent cytotoxic T-lymphocyte (CTL) response against EpCAM-expressing epithelial tumor cells. Fc-mediated binding of APCs in the tricellular complex potentiates EpCAM antigen presentation to T cells and the activation of anti-tumor cytotoxic T cell functions. (NCI Thesaurus)

YOU MAY ALSO LIKE

Cationic Liposome-Encapsulated Paclitaxel

A cationic liposome preparation of paclitaxel with antineoplastic activity. Paclitaxel, the active ingredient in cationic liposome-encapsulated paclitaxel, binds to tubulin and inhibits…

Cation-Independent Mannose-6 Phosphate Receptor

Cation-independent mannose-6-phosphate receptor (2491 aa, ~274 kDa) is encoded by the human IGF2R gene. This protein is involved in receptor-mediated endocytosis. …

Cation Channel Blocker

A group of agents that block the influx or efflux of positively charged ions through cell membrane.

Cathode Ray Tube Device Component

An evacuated glass tube designed to accelerate electrons onto a screen to create images.

Catheterization

A technique in which a hollow, flexible tube is used to drain body fluids or to introduce fluids into the body, or…

Catheter-Related Infection

An infection that arises secondary to catheter use.